Bopindolol in the treatment of hypertension: a double blind study comparing bopindolol and metoprolol. 1989

K Lefflerová, and Z Lupínek, and J Widimský, and Z Lupínková, and O Uhlír, and P Miklis, and K Zeman, and J Zicha
Department of Cardiology, Postgraduate Medical and Pharmaceutical Institute, Prague, Czechoslovakia.

The article presents the experience gained with a new betablocker- bopindolol-in the treatment of hypertension. Using a three-month double blind study conducted in 2 centres, the antihypertensive effect of bopindolol and metoprolol was compared in a total of 86 patients. The incidence of undesirable effects was determined, and biochemical parameters before and after therapy were followed up. Both drugs were equally effective in controlling blood pressure. In 70% of patients with mild and moderate hypertension, diastolic pressure values less than 95 mmHg were obtained in monotherapy with a betablocker. The incidence of undesirable effects was low, the drug was tolerated well. Biochemical parameters did not change within the three months of study.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008790 Metoprolol A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS. Beloc-Duriles,Betaloc,Betaloc-Astra,Betalok,CGP-2175,H 93-26,Lopressor,Metoprolol CR-XL,Metoprolol Succinate,Metoprolol Tartrate,Seloken,Spesicor,Spesikor,Toprol,Toprol-XL,Beloc Duriles,Betaloc Astra,CGP 2175,CGP2175,H 93 26,H 9326,Metoprolol CR XL,Toprol XL
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010869 Pindolol A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638) Prindolol,LB-46,Visken,LB 46,LB46
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K Lefflerová, and Z Lupínek, and J Widimský, and Z Lupínková, and O Uhlír, and P Miklis, and K Zeman, and J Zicha
January 1986, European journal of clinical pharmacology,
K Lefflerová, and Z Lupínek, and J Widimský, and Z Lupínková, and O Uhlír, and P Miklis, and K Zeman, and J Zicha
January 1991, Journal of cardiovascular pharmacology,
K Lefflerová, and Z Lupínek, and J Widimský, and Z Lupínková, and O Uhlír, and P Miklis, and K Zeman, and J Zicha
May 1979, The Medical journal of Australia,
K Lefflerová, and Z Lupínek, and J Widimský, and Z Lupínková, and O Uhlír, and P Miklis, and K Zeman, and J Zicha
January 1990, Medicinski pregled,
K Lefflerová, and Z Lupínek, and J Widimský, and Z Lupínková, and O Uhlír, and P Miklis, and K Zeman, and J Zicha
January 1986, Acta cardiologica,
K Lefflerová, and Z Lupínek, and J Widimský, and Z Lupínková, and O Uhlír, and P Miklis, and K Zeman, and J Zicha
January 1984, European journal of clinical pharmacology,
K Lefflerová, and Z Lupínek, and J Widimský, and Z Lupínková, and O Uhlír, and P Miklis, and K Zeman, and J Zicha
January 1981, Annals of clinical research,
K Lefflerová, and Z Lupínek, and J Widimský, and Z Lupínková, and O Uhlír, and P Miklis, and K Zeman, and J Zicha
January 1979, European journal of clinical pharmacology,
K Lefflerová, and Z Lupínek, and J Widimský, and Z Lupínková, and O Uhlír, and P Miklis, and K Zeman, and J Zicha
December 1988, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
K Lefflerová, and Z Lupínek, and J Widimský, and Z Lupínková, and O Uhlír, and P Miklis, and K Zeman, and J Zicha
January 1974, Acta cardiologica,
Copied contents to your clipboard!